Net sales of insulin medications of Novo Nordisk in Greater China 2019, by type

In 2019, the Danish pharmaceutical company Novo Nordisk reported a net sales of over 4.3 billion Danish kroner from its premix insulin in Greater China. Diabetes care drug is the key product of the firm, generating over 12.5 billion net sales in the region that year.

…. more: Statista.com (Quelle/Source)